Facility #1

Cluj-Napoca, Cluj 400058

0 studies enrolling now · 1 studies all time

What they study most

Thyroid Cancer

Studies at this site

• A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile — Completed